A business in context

RKDA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-31 · 0001193125-26-383642 · Items 3.01,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-349205

  3. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-349180 · Items 2.02,9.01

  4. DEF 14A · Proxy statement

    Report date 2026-08-10 · 0001193125-26-342437

  5. 8-K · Current report

    Report date 2026-08-04 · 0001193125-26-340664 · Items 3.01,9.01

  6. 8-K · Current report

    Report date 2026-07-01 · 0001193125-26-294619 · Items 5.02,5.08,8.01

  7. 8-K · Current report

    Report date 2026-06-11 · 0001193125-26-270560 · Items 1.01,3.02,7.01,9.01

  8. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-223990

  9. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-223985 · Items 2.02,9.01

  10. 10-K/A · Annual report

    Report date 2025-12-31 · 0001193125-26-197315

  11. 8-K · Current report

    Report date 2026-03-30 · 0001193125-26-142030 · Items 4.01,9.01

  12. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-126238

  13. 8-K · Current report

    Report date 2026-03-26 · 0001193125-26-126220 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-02-04 · 0001193125-26-041144 · Items 5.02,9.01

  15. 8-K · Current report

    Report date 2026-01-09 · 0001193125-26-012028 · Items 1.01,3.02,3.03,7.01,9.01

  16. 8-K · Current report

    Report date 2025-12-24 · 0001193125-25-335410 · Items 1.02,7.01,9.01

  17. 8-K · Current report

    Report date 2025-12-19 · 0001193125-25-331009 · Items 5.07

  18. DEF 14A · Proxy statement

    Report date 2025-12-19 · 0001193125-25-288164

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-272375

  20. 8-K · Current report

    Report date 2025-11-07 · 0001193125-25-272368 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-10-22 · 0001193125-25-249854 · Items 5.08,8.01,9.01

  22. 8-K · Current report

    Report date 2025-08-26 · 0000950170-25-112267 · Items 5.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-109040

  24. 8-K · Current report

    Report date 2025-08-14 · 0000950170-25-108983 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-05-14 · 0000950170-25-073711 · Items 7.01,8.01,9.01

  26. 4 · Ownership change

    Report date 2025-05-09 · 0000950170-25-069633

  27. 4 · Ownership change

    Report date 2025-05-09 · 0000950170-25-069626

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066425

  29. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066420 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-04-30 · 0000950170-25-062913 · Items 1.01,9.01

  31. 10-K/A · Annual report

    Report date 2024-12-31 · 0000950170-25-061044

  32. 8-K · Current report

    Report date 2025-03-28 · 0000950170-25-050406 · Items 1.01,9.01

  33. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-044487

  34. 8-K · Current report

    Report date 2025-03-20 · 0000950170-25-042647 · Items 2.02,9.01

  35. 4 · Ownership change

    Report date 2025-02-03 · 0000950170-25-014814

  36. 4 · Ownership change

    Report date 2025-02-03 · 0000950170-25-014802

  37. 4 · Ownership change

    Report date 2024-08-19 · 0000950170-24-099644

  38. 4 · Ownership change

    Report date 2024-08-19 · 0000950170-24-099639

  39. 4 · Ownership change

    Report date 2024-08-19 · 0000950170-24-099625

  40. 4 · Ownership change

    Report date 2024-08-19 · 0000950170-24-099621

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001469443Arcadia Biosciences, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$5.04M$5.37M
    2023-12-31$4.45M$4.88M
    2022-12-31$7.42M$8.46M
    2021-12-31$6.78M$8.35M
    2020-12-31$8.03M$10.37M
    2019-12-31$1.17M$1.53M
    2018-12-31$1.46M$1.95M
    2017-12-31$4.03M$5.48M

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗